InvestorsHub Logo
Followers 51
Posts 4564
Boards Moderated 0
Alias Born 12/14/2009

Re: Biotech Pharmer post# 2475

Wednesday, 04/05/2017 7:43:47 AM

Wednesday, April 05, 2017 7:43:47 AM

Post# of 5907
Look to the history of different biotech companies: all dilute before bad news.
If they would expect the news was good, they would have gotten the same amount of money without diluting this many shares.
If yhe expect the news is bad, they dilute before news, because other wise the share price implodes and it gets much more difficult to raise capital.

It is going to be bad news from EMA. IMO.